Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
AcuCort ABXSAT:ACUC -3.23%32 Gross Margin % is 233.42% as of Jun. 2026, which is 78% below its 10-year median of 1,058.02. GuruFocus rates XSAT:ACUC with a GF Score™ of 32/100. Among 939 Drug Manufacturers companies, AcuCort AB ranks better than 99.89% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. AcuCort AB's Gross Profit for the
three
months ended in Jun. 2026 was kr2.70 Mil. AcuCort AB's Revenue for the
three
months ended in Jun. 2026 was kr1.16 Mil. Therefore, AcuCort AB's Gross Margin % for the quarter that ended in Jun. 2026 was 233.42%.
The historical rank and industry rank for AcuCort AB's Gross Margin % or its related term are showing as below:
XSAT:ACUC'
s Gross Margin % Range Over the Past 10 Years
Min: 524.72 Med: 1058.02 Max: 1143.26
Current: 524.72
During the past 12 years, the highestGross Margin % of AcuCort AB was 1143.26%. The lowest was 524.72%. And the median was 1058.02%.
XSAT:ACUC's Gross Margin % is ranked better than 99.89% of 939
companies
in the Drug Manufacturers industry
Industry Median: 48.54
vs XSAT:ACUC: 524.72
AcuCort AB had a gross margin of 233.42% for the quarter that ended in Jun. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for AcuCort AB was 0.00% per year.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
AcuCort AB had a gross margin of 233.42% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
AcuCort AB Gross Margin % Related Terms
AcuCort AB Gross Margin % Historical Data
* Premium members only.
The historical data trend for AcuCort AB's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, AcuCort AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AcuCort AB Gross Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AcuCort AB's Gross Margin % distribution charts can be found below:
* The bar in red indicates where AcuCort AB's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
AcuCort AB (XSAT:ACUC) has a Gross Margin % of 233.42% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on AcuCort AB and its competitors. This is 78% below median its historical median of 1,058.02. Over the past decade, AcuCort AB's Gross Margin % has ranged from 524.72 to 1,143.26. According to the industry distribution chart, AcuCort AB ranks #1 out of 939 companies in the Drug Manufacturers industry, placing it in the top 0.099999999999994%.
Is AcuCort AB's Gross Margin % too high?
AcuCort AB's current Gross Margin % of 233.42% is 78% below median its 10-year median of 1,058.02. Over the past 10 years, this metric has ranged from a low of 524.72 to a high of 1,143.26. The Drug Manufacturers industry median Gross Margin % is 48.54. AcuCort AB's value of 233.42% is 380.9% above this industry median. Based on the distribution chart, AcuCort AB ranks #1 out of 939 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, AcuCort AB has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does AcuCort AB's Gross Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, AcuCort AB ranks #1 out of 939 companies for Gross Margin %. This places AcuCort AB in the top 0% of its industry — outperforming the majority of peers. The industry median Gross Margin % is 48.54. AcuCort AB's value of 233.42% is 380.9% above this benchmark. Historically, AcuCort AB's own Gross Margin % has ranged from 524.72 to 1,143.26 over the past decade. While the company's 10-year median is 1,058.02 vs. the industry median of 48.54, AcuCort AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Drug Manufacturers company?
The median Gross Margin % among Drug Manufacturers companies is 48.54, based on 939 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AcuCort AB's current Gross Margin % of 233.42% is 380.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on AcuCort AB and its competitors. For the Drug Manufacturers industry, the median Gross Margin % is 48.54 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AcuCort AB's current Gross Margin % is 233.42%, which is 78% below median its own 10-year median of 1,058.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AcuCort AB stock overvalued right now?
AcuCort AB (XSAT:ACUC) has a current Gross Margin % of 233.42%. The current Gross Margin % is 233.42%, which is 78% below median its 10-year median of 1,058.02 and 380.9% above the Drug Manufacturers industry median of 48.54. AcuCort AB's overall GF Score™ is 32/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For AcuCort AB (XSAT:ACUC), the current Gross Margin % is 233.42% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
AcuCort AB is an innovative biotechnology company that identifies, develops and commercializes smart drugs that meet the patient's needs for a user-friendly and effective treatment.
32GF Score
Get the complete analysis for XSAT:ACUC
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSAT:ACUC has been successfully added to your 
